News Features Funding the Future: How Industry Support for CV Trials Could Evolve Michael O'Riordan December 17, 2020
News Daily News FDA Approves Lotus Edge, Ushering Third Device Into US Market Shelley Wood April 24, 2019
News Daily News FDA Approves Resolute Onyx, Billed as Slimmest Stent Yet on US Market Yael L. Maxwell February 26, 2018
News Daily News TAVR as an Option for Intermediate-Risk Patients: Physicians Respond Yael L. Maxwell August 24, 2016